These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 2433373

  • 21. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
    Griffiths RJ, Moore PK.
    Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
    [Abstract] [Full Text] [Related]

  • 22. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.
    Cattaneo M, Canciani MT, Lecchi A, Kinlough-Rathbone RL, Packham MA, Mannucci PM, Mustard JF.
    Blood; 1990 Mar 01; 75(5):1081-6. PubMed ID: 2137716
    [Abstract] [Full Text] [Related]

  • 23. Quantitation of platelet preservation with prostanoids during simulated bypass.
    Kappa JR, Musial J, Fisher CA, Addonizio VP.
    J Surg Res; 1987 Jan 01; 42(1):10-8. PubMed ID: 2433503
    [Abstract] [Full Text] [Related]

  • 24. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M, Welzel D, Wolf H, Honey A, Kakkar VV.
    Arzneimittelforschung; 1987 Jun 01; 37(6):669-74. PubMed ID: 2822055
    [Abstract] [Full Text] [Related]

  • 25. Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect.
    Rao AK, Willis J, Kowalska MA, Wachtfogel YT, Colman RW.
    Blood; 1988 Feb 01; 71(2):494-501. PubMed ID: 2827817
    [Abstract] [Full Text] [Related]

  • 26. Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury.
    Kahn N, Sinha A, Bauman W.
    Clin Physiol; 2001 Jan 01; 21(1):60-6. PubMed ID: 11168298
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG, Wong T, Frojmovic MM.
    Thromb Haemost; 1988 Apr 08; 59(2):323-8. PubMed ID: 2455359
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Kikura M, Kazama T, Ikeda T, Sato S.
    Platelets; 2000 Dec 08; 11(8):446-58. PubMed ID: 11177444
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
    Miyamori I, Morise T, Yasuhara S, Takeda Y, Koshida H, Takeda R.
    Br J Clin Pharmacol; 1985 Dec 08; 20(6):681-3. PubMed ID: 3912001
    [Abstract] [Full Text] [Related]

  • 33. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.
    Stürzebecher S, Nieuweboer B, Matthes S, Schillinger E.
    Prog Clin Biol Res; 1989 Dec 08; 301():365-9. PubMed ID: 2477855
    [No Abstract] [Full Text] [Related]

  • 34. Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue.
    Elias M, Heethuis A, Weggemans M, Bom V, Blom N, McShine RL, Halie MR, Smit Sibinga CT.
    Ann Hematol; 1992 Jun 08; 64(6):292-8. PubMed ID: 1379080
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Iloprost binding and inhibition of aggregation in platelet rich plasma. Differences between normal and type IIa hypercholesterolemic subjects.
    Oliva DW, Maderna P, Accomazzo MR, Nicosia S, Tremoli E.
    Biochem Pharmacol; 1989 Jan 01; 38(1):39-45. PubMed ID: 2462881
    [Abstract] [Full Text] [Related]

  • 38. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
    Nogimori K, Kajikawa N, Nishio S, Yajima M.
    Prostaglandins; 1989 Feb 01; 37(2):205-12. PubMed ID: 2543034
    [Abstract] [Full Text] [Related]

  • 39. Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.
    Schafer AI, Zavoico GB, Loscalzo J, Maas AK.
    Blood; 1987 May 01; 69(5):1504-7. PubMed ID: 3032310
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.